CHMP3 and triple-negative breast carcinoma: MiR-122-5p promotes aggression and epithelial–mesenchymal transition in triple-negative breast cancer, by suppressing charged multivesicular body protein 3 (CHMP3) through mitogen-activated protein kinase (MAPK) signaling [37].